Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Prepaid Assets (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Prepaid Assets for 16 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 210.2% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, up 210.2% year-over-year, with the annual reading at $1.7 million for FY2025, 210.2% up from the prior year.
  • Prepaid Assets for Q4 2025 was $1.7 million at Plus Therapeutics, up from $985000.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $3.0 million in Q4 2022, with the low at $406000.0 in Q1 2025.
  • Average Prepaid Assets over 5 years is $943210.5, with a median of $840000.0 recorded in 2021.
  • The sharpest move saw Prepaid Assets tumbled 86.33% in 2023, then skyrocketed 210.2% in 2025.
  • Over 5 years, Prepaid Assets stood at $817000.0 in 2021, then skyrocketed by 267.07% to $3.0 million in 2022, then crashed by 86.33% to $410000.0 in 2023, then soared by 36.34% to $559000.0 in 2024, then surged by 210.2% to $1.7 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $1.7 million, $985000.0, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.